1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Someya, T.
Muto, Y.
Inoue, M.
Kigawa, T.
Terada, T.
Shirouzu, M.
Yokoyama, S.
RIKEN Structural Genomics/Proteomics Initiative (RSGI)
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
To be Published
0353
Solution Structure of the RNA recognition motif in Peptidyl-prolyl cis-trans isomerase E
10.2210/pdb2cqb/pdb
pdb_00002cqb
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
11018.311
Peptidyl-prolyl cis-trans isomerase E
5.2.1.8
RNA recognition motif
1
man
polymer
PPIase E, Rotamase E, Cyclophilin E, Cyclophilin 33
no
no
GSSGSSGMATTKRVLYVGGLAEEVDDKVLHAAFIPFGDITDIQIPLDYETEKHRGFAFVEFELAEDAAAAIDNMNESELF
GRTIRVNLAKPMRIKESGPSSG
GSSGSSGMATTKRVLYVGGLAEEVDDKVLHAAFIPFGDITDIQIPLDYETEKHRGFAFVEFELAEDAAAAIDNMNESELF
GRTIRVNLAKPMRIKESGPSSG
A
hss001001135.1
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
sample
Cell-free protein synthesis
PPIE
9606
Homo sapiens
PLASMID
P040517-01
RIKEN Structural Genomics/Proteomics Initiative
RSGI
NPPSFA, National Project on Protein Structural and Functional Analyses
database_2
pdbx_nmr_software
pdbx_nmr_spectrometer
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2005-11-19
1
1
2008-04-30
1
2
2011-07-13
1
3
2022-03-09
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_pdbx_nmr_spectrometer.model
_struct_ref_seq_dif.details
HELIX
DETERMINATION METHOD: AUTHOR DETERMINED
SHEET
DETERMINATION METHOD: AUTHOR DETERMINED
Y
PDBJ
Y
PDBJ
2005-05-19
REL
REL
target function, structures with the lowest energy, structures with the least restraint violations
100
20
3D_15N-separated_NOESY
3D_13C-separated_NOESY
120mM
7.0
ambient
298
K
torsion angle dynamics, restrainted molecular dynamics
1
lowest energy
1.16mM PROTEIN U-15N,13C; 20mM d-Tris-HCL(pH7.0); 100mM NaCl; 1mM d-DTT; 0.02% NaN3; 10% D2O
90% H2O/10% D2O
Bruker
collection
XwinNMR
3.5
Delaglio, F.
processing
NMRPipe
20030801
Johnson, B.A.
data analysis
NMRView
5.0.4
Kobayashi, N.
data analysis
KUJIRA
0.9295
Guntert, P.
structure solution
CYANA
2.0.17
Guntert, P.
refinement
CYANA
2.0.17
700
Bruker
AVANCE
GLY
-6
n
1
GLY
-6
A
SER
-5
n
2
SER
-5
A
SER
-4
n
3
SER
-4
A
GLY
-3
n
4
GLY
-3
A
SER
-2
n
5
SER
-2
A
SER
-1
n
6
SER
-1
A
GLY
0
n
7
GLY
0
A
MET
1
n
8
MET
1
A
ALA
2
n
9
ALA
2
A
THR
3
n
10
THR
3
A
THR
4
n
11
THR
4
A
LYS
5
n
12
LYS
5
A
ARG
6
n
13
ARG
6
A
VAL
7
n
14
VAL
7
A
LEU
8
n
15
LEU
8
A
TYR
9
n
16
TYR
9
A
VAL
10
n
17
VAL
10
A
GLY
11
n
18
GLY
11
A
GLY
12
n
19
GLY
12
A
LEU
13
n
20
LEU
13
A
ALA
14
n
21
ALA
14
A
GLU
15
n
22
GLU
15
A
GLU
16
n
23
GLU
16
A
VAL
17
n
24
VAL
17
A
ASP
18
n
25
ASP
18
A
ASP
19
n
26
ASP
19
A
LYS
20
n
27
LYS
20
A
VAL
21
n
28
VAL
21
A
LEU
22
n
29
LEU
22
A
HIS
23
n
30
HIS
23
A
ALA
24
n
31
ALA
24
A
ALA
25
n
32
ALA
25
A
PHE
26
n
33
PHE
26
A
ILE
27
n
34
ILE
27
A
PRO
28
n
35
PRO
28
A
PHE
29
n
36
PHE
29
A
GLY
30
n
37
GLY
30
A
ASP
31
n
38
ASP
31
A
ILE
32
n
39
ILE
32
A
THR
33
n
40
THR
33
A
ASP
34
n
41
ASP
34
A
ILE
35
n
42
ILE
35
A
GLN
36
n
43
GLN
36
A
ILE
37
n
44
ILE
37
A
PRO
38
n
45
PRO
38
A
LEU
39
n
46
LEU
39
A
ASP
40
n
47
ASP
40
A
TYR
41
n
48
TYR
41
A
GLU
42
n
49
GLU
42
A
THR
43
n
50
THR
43
A
GLU
44
n
51
GLU
44
A
LYS
45
n
52
LYS
45
A
HIS
46
n
53
HIS
46
A
ARG
47
n
54
ARG
47
A
GLY
48
n
55
GLY
48
A
PHE
49
n
56
PHE
49
A
ALA
50
n
57
ALA
50
A
PHE
51
n
58
PHE
51
A
VAL
52
n
59
VAL
52
A
GLU
53
n
60
GLU
53
A
PHE
54
n
61
PHE
54
A
GLU
55
n
62
GLU
55
A
LEU
56
n
63
LEU
56
A
ALA
57
n
64
ALA
57
A
GLU
58
n
65
GLU
58
A
ASP
59
n
66
ASP
59
A
ALA
60
n
67
ALA
60
A
ALA
61
n
68
ALA
61
A
ALA
62
n
69
ALA
62
A
ALA
63
n
70
ALA
63
A
ILE
64
n
71
ILE
64
A
ASP
65
n
72
ASP
65
A
ASN
66
n
73
ASN
66
A
MET
67
n
74
MET
67
A
ASN
68
n
75
ASN
68
A
GLU
69
n
76
GLU
69
A
SER
70
n
77
SER
70
A
GLU
71
n
78
GLU
71
A
LEU
72
n
79
LEU
72
A
PHE
73
n
80
PHE
73
A
GLY
74
n
81
GLY
74
A
ARG
75
n
82
ARG
75
A
THR
76
n
83
THR
76
A
ILE
77
n
84
ILE
77
A
ARG
78
n
85
ARG
78
A
VAL
79
n
86
VAL
79
A
ASN
80
n
87
ASN
80
A
LEU
81
n
88
LEU
81
A
ALA
82
n
89
ALA
82
A
LYS
83
n
90
LYS
83
A
PRO
84
n
91
PRO
84
A
MET
85
n
92
MET
85
A
ARG
86
n
93
ARG
86
A
ILE
87
n
94
ILE
87
A
LYS
88
n
95
LYS
88
A
GLU
89
n
96
GLU
89
A
SER
90
n
97
SER
90
A
GLY
91
n
98
GLY
91
A
PRO
92
n
99
PRO
92
A
SER
93
n
100
SER
93
A
SER
94
n
101
SER
94
A
GLY
95
n
102
GLY
95
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
ASN
66
-92.11
-74.91
1
A
MET
85
-53.91
175.04
1
A
ARG
86
-170.27
105.08
1
A
SER
94
37.85
41.98
2
A
ARG
47
-82.70
42.08
2
A
ALA
50
-175.16
-176.08
2
A
ASN
66
-90.85
-74.30
3
A
SER
-2
-56.08
175.36
3
A
ILE
32
-51.61
100.21
3
A
ARG
47
-87.06
42.95
3
A
ASP
65
-39.24
-27.00
3
A
ASN
66
-99.40
-73.46
3
A
ASN
68
-36.21
115.76
3
A
LYS
88
-170.27
110.14
4
A
THR
3
-134.40
-43.95
4
A
THR
4
-166.02
112.70
4
A
ASP
65
-39.92
-28.47
4
A
ASN
66
-98.07
-71.28
4
A
ASN
68
-35.18
117.25
4
A
ALA
82
-49.33
158.07
4
A
ARG
86
-172.91
129.26
4
A
ILE
87
-118.59
69.21
4
A
PRO
92
-69.80
3.27
4
A
SER
93
74.82
50.95
5
A
ASP
19
-39.19
-31.61
5
A
PHE
29
-39.47
-73.64
5
A
ASN
66
-93.82
-74.91
5
A
MET
85
-39.07
142.25
5
A
LYS
88
-82.81
36.35
6
A
SER
-4
-64.52
94.78
6
A
SER
-2
-79.22
48.25
6
A
LYS
5
-134.66
-39.42
6
A
PHE
29
-37.14
-72.45
6
A
ASN
66
-94.78
-74.32
6
A
PRO
92
-69.82
-170.47
7
A
SER
-2
-48.23
165.52
7
A
ALA
2
-131.78
-62.30
7
A
THR
4
-46.07
101.08
7
A
PHE
29
-43.26
-74.03
7
A
ILE
32
-61.65
93.44
7
A
ALA
50
-171.70
-179.38
7
A
ASN
66
-97.69
-74.52
7
A
MET
67
-39.10
-36.84
7
A
GLU
89
-172.25
112.06
7
A
PRO
92
-69.85
-176.02
8
A
ALA
2
-173.05
146.46
8
A
LYS
5
-106.46
45.82
8
A
ASP
19
-35.80
-39.12
8
A
ASP
31
-60.70
75.99
8
A
ILE
32
-36.12
119.94
8
A
ALA
50
-173.56
-179.63
8
A
ASP
65
-49.64
-19.99
8
A
ASN
66
-104.49
-74.93
8
A
ASN
68
-38.60
113.56
8
A
LYS
88
36.94
29.67
8
A
SER
93
-162.65
117.25
9
A
MET
1
-134.36
-53.04
9
A
THR
3
34.32
42.63
9
A
ARG
6
-131.64
-36.19
9
A
PHE
29
-50.99
-71.09
9
A
ASP
31
-117.75
75.19
9
A
ILE
32
-35.81
120.06
9
A
PRO
38
-69.78
97.57
9
A
GLU
44
46.29
29.09
9
A
ALA
50
-170.71
-175.29
9
A
ASN
66
-104.12
-73.20
9
A
ASN
68
-39.75
116.21
9
A
ALA
82
-46.05
102.93
9
A
LYS
83
-46.01
152.44
10
A
SER
-2
-59.95
171.35
10
A
ILE
32
-51.78
103.13
10
A
ARG
47
-85.65
31.35
10
A
ASN
66
-98.23
-74.79
10
A
ALA
82
-45.11
106.58
10
A
LYS
83
-46.87
150.13
10
A
GLU
89
-107.66
-61.00
11
A
SER
-2
-52.81
173.33
11
A
LYS
5
-94.32
42.42
11
A
PHE
29
-36.36
-70.40
11
A
ALA
50
-170.59
-177.51
11
A
ASN
66
-98.38
-73.29
11
A
SER
93
-122.71
-55.13
12
A
SER
-2
-64.44
88.83
12
A
ALA
2
-61.28
96.63
12
A
THR
4
-69.78
70.78
12
A
LYS
5
-78.84
48.77
12
A
ASP
19
-38.75
-38.21
12
A
PHE
29
-49.22
-73.52
12
A
ILE
32
-38.71
144.49
12
A
ALA
50
-171.20
-176.82
12
A
ASP
65
-39.98
-25.36
12
A
ASN
66
-102.54
-74.43
12
A
ASN
68
-34.77
116.27
12
A
ALA
82
-46.89
107.66
12
A
LYS
83
-49.98
152.63
12
A
SER
94
-166.91
107.08
13
A
LYS
5
-98.71
36.84
13
A
PHE
29
-52.83
-71.76
13
A
ASP
31
-115.00
78.65
13
A
ILE
32
-35.88
122.17
13
A
ASN
66
-109.35
-74.08
13
A
MET
67
-34.78
-32.70
13
A
PRO
92
-69.70
-173.56
14
A
SER
-5
-161.52
114.69
14
A
ALA
2
-79.42
46.54
14
A
ASN
66
-95.40
-73.01
14
A
MET
85
-41.41
151.79
15
A
MET
1
-92.56
55.01
15
A
LYS
5
-103.11
42.83
15
A
ASP
19
-36.13
-38.64
15
A
ASN
66
-93.75
-73.25
15
A
ARG
86
-32.25
129.42
15
A
PRO
92
-69.80
-177.12
16
A
SER
-4
-174.65
139.62
16
A
PHE
29
-38.08
-73.12
16
A
ASP
31
-111.60
79.85
16
A
ILE
32
-36.93
124.99
16
A
ASP
40
-53.91
-176.37
16
A
ASP
65
-38.25
-27.21
16
A
ASN
66
-101.54
-74.85
16
A
PRO
84
-69.76
-163.54
17
A
SER
-1
-160.97
106.73
17
A
MET
1
-40.98
151.87
17
A
PHE
29
-43.86
-72.25
17
A
ASP
31
-110.08
73.07
17
A
ILE
32
-38.24
119.89
17
A
ASN
66
-96.30
-74.95
18
A
SER
-4
-93.53
42.88
18
A
MET
1
-41.56
152.98
18
A
THR
4
71.43
53.47
18
A
LYS
5
-81.46
42.06
18
A
GLU
44
39.68
42.00
18
A
ASP
65
-37.94
-27.34
18
A
ASN
66
-96.07
-74.18
18
A
MET
67
-36.66
-32.03
18
A
LYS
83
-44.85
155.53
18
A
MET
85
-45.05
160.91
19
A
SER
-4
-87.44
42.12
19
A
ASN
66
-93.92
-74.42
19
A
MET
67
-37.89
-39.02
19
A
PHE
73
46.88
26.24
19
A
GLU
89
-172.29
117.32
20
A
MET
1
-61.93
97.25
20
A
LEU
13
-55.39
-178.29
20
A
ILE
32
-39.60
120.75
20
A
ASN
66
-94.28
-75.19
20
A
SER
90
-122.72
-53.74
Solution Structure of the RNA recognition motif in Peptidyl-prolyl cis-trans isomerase E
1
N
N
A
ASP
19
A
ASP
26
HELX_P
A
ALA
24
A
ALA
31
1
1
6
A
GLU
58
A
GLU
65
HELX_P
A
MET
67
A
MET
74
1
2
10
ISOMERASE
RNA recognition motif, Structural Genomics, NPPSFA, National Project on Protein Structural and Functional Analyses, RIKEN Structural Genomics/Proteomics Initiative, RSGI, Isomerase
PPIE_HUMAN
UNP
1
1
Q9UNP9
MATTKRVLYVGGLAEEVDDKVLHAAFIPFGDITDIQIPLDYETEKHRGFAFVEFELAEDAAAAIDNMNESELFGRTIRVN
LAKPMRIKE
1
89
2CQB
1
89
Q9UNP9
A
1
8
96
1
cloning artifact
GLY
-6
2CQB
A
Q9UNP9
UNP
1
1
cloning artifact
SER
-5
2CQB
A
Q9UNP9
UNP
2
1
cloning artifact
SER
-4
2CQB
A
Q9UNP9
UNP
3
1
cloning artifact
GLY
-3
2CQB
A
Q9UNP9
UNP
4
1
cloning artifact
SER
-2
2CQB
A
Q9UNP9
UNP
5
1
cloning artifact
SER
-1
2CQB
A
Q9UNP9
UNP
6
1
cloning artifact
GLY
0
2CQB
A
Q9UNP9
UNP
7
1
cloning artifact
SER
90
2CQB
A
Q9UNP9
UNP
97
1
cloning artifact
GLY
91
2CQB
A
Q9UNP9
UNP
98
1
cloning artifact
PRO
92
2CQB
A
Q9UNP9
UNP
99
1
cloning artifact
SER
93
2CQB
A
Q9UNP9
UNP
100
1
cloning artifact
SER
94
2CQB
A
Q9UNP9
UNP
101
1
cloning artifact
GLY
95
2CQB
A
Q9UNP9
UNP
102
4
anti-parallel
anti-parallel
anti-parallel
A
LEU
8
A
LEU
15
A
GLY
11
A
GLY
18
A
ILE
35
A
ILE
42
A
ILE
37
A
ILE
44
A
PHE
49
A
PHE
56
A
VAL
52
A
VAL
59
A
ARG
78
A
ARG
85
A
ASN
80
A
ASN
87